GP2A 2019 – Confirmed Speakers

Prof. Stephen Husbands

Department of Pharmacy & Pharmacology, Centre for Therapeutic Innovation, University of Bath (UK)

Prof. Paul Leeson

Paul Leeson Consulting. Honorary Prof. of Medicinal Chemistry, School of Pharmacy, University of Nottingham (UK)

 Dr Vania Moreira

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde (UK)



 Dr Geoffrey Wells

School of Pharmacy, University College London (UK)

Prof. Mike Waring

Northern Institute for Cancer Research, Newcastle University (UK)

Dr Chris De Graaf
Director of Computational Chemistry, Sosei Heptares, Cambridge (UK)

Prof. Paul Wyatt
Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee (UK)

Prof. John F. Gilmer
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin (Ireland)
Prof. Pierre Verhaeghe
Faculty of Pharmaceutical Sciences, Paul Sabatier University; CNRS, Toulouse (France)
Between 1997 & 2007, Pierre Verhaeghe studied Pharmacy and Organic Chemistry at the Universities of Caen, Rennes I and Aix-Marseille, where he was also pharmacy resident at the public teaching hospital (AP-HM). After a post-doc experience in the pharmaceutical industry at the J&J research center of Val de Reuil in 2008, PV joined academic research and is now, since 2013, professor of medicinal chemistry at the faculty of pharmaceutical sciences of Paul Sabatier university and team leader at the Laboratoire de Chimie de Coordination (UPR 8241) of the CNRS in Toulouse. The research activities of PV mainly focus on the design, synthesis and study of the mechanism of action of molecular or macromolecular anti-infective compounds targeting human pathogens such as intracellular protozoa (P. falciparum, Leishmania spp, Trypanosoma spp) or anaerobic bacteria (C. difficile).
Dr Nuria Cabedo
Instituto de Investigación Sanitaria INCLIVA (Spain)
I received my PhD in Pharmacy from the University of Valencia (2000), in the group of Prof. D. Cortes. From 2001-2004, I was a postdoctoral research fellow at several institutions (IRCOF, Rouen, CERMN, Caen, Chemistry Dept. of the University of Manchester). In 2005, I returned as postdoctoral researcher at the Centro de Ecología Química Agrícola of the Polytechnic University of Valencia. In 2015, I worked in the Biotechnology Company Biopolis of the Scientific Park of the University of Valencia.
Since 2016, I was hired by the Biomedical Research Institute INCLIVA of the Foundation for the Research of the Hospital Clínico Universitario of Valencia. I have participated in 5 regionally/nationally funded projects andam a member of the Research Strategy in Personalized Medicine and Development of Innovative Medicines within the RIS3 measures framework and the COST Action MuTaLig. Since 2011, I have taught at both graduate and postgraduate levels within the Pharmacology Department, University of Valencia as an associate/invited professor.
My research interests include the medicinal chemistry of natural products and synthetic analogues focused mainly on dopaminergic receptors, mitochondrial respiratory chain inhibitors, anti-inflammatory agents and PPARs, in order to treat cardiometabolic disorders and neurological diseases. 
Scroll to Top